Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,910 | 3 | 85.6% |
| Travel and Lodging | $800.84 | 4 | 9.9% |
| Food and Beverage | $362.09 | 10 | 4.5% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $5,760 | 13 | $0 (2024) |
| GENZYME CORPORATION | $2,278 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $21.30 | 1 | $0 (2023) |
| Advanced Respiratory, Inc | $13.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,930 | 13 | GlaxoSmithKline, LLC. ($5,665) |
| 2023 | $21.30 | 1 | AstraZeneca Pharmaceuticals LP ($21.30) |
| 2022 | $13.36 | 1 | GENZYME CORPORATION ($13.36) |
| 2021 | $108.24 | 2 | GlaxoSmithKline, LLC. ($95.00) |
| 2018 | $0 | 1 | Breathe Technologies, Inc. |
| 2017 | $0 | 1 | Breathe Technologies, Inc. |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 12/12/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $142.01 | General |
| 12/12/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 11/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $81.40 | General |
| 11/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 11/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $23.56 | General |
| 11/15/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $210.90 | General |
| 11/15/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $81.40 | General |
| 11/15/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.75 | General |
| 11/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $416.91 | General |
| 10/24/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 10/19/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,265.00 | General |
| 05/23/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 11/14/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Immunology | ||||||
| 10/28/2021 | Advanced Respiratory, Inc | Volara System (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Airway Clearance Device | ||||||
| 06/14/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $95.00 | General |
| Category: IMMUNOLOGY | ||||||
| 2018 | Breathe Technologies, Inc. | — | — | — | $0.00 | Ownership |
| 2017 | Breathe Technologies, Inc. | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 97 | 106 | $22,057 | $9,658 |
| 2022 | 4 | 87 | 96 | $19,525 | $9,325 |
| 2021 | 4 | 96 | 106 | $21,740 | $10,162 |
| 2020 | 4 | 108 | 118 | $24,630 | $10,032 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 39 | $8,091 | $4,406 | 54.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 29 | $4,415 | $2,100 | 47.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $3,842 | $1,756 | 45.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 25 | 25 | $5,709 | $1,396 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 29 | 32 | $6,560 | $3,726 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 33 | $4,950 | $2,445 | 49.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $4,640 | $2,382 | 51.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 15 | 15 | $3,375 | $771.12 | 22.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 29 | $5,945 | $3,477 | 58.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 36 | $5,400 | $2,851 | 52.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 18 | 18 | $5,220 | $2,567 | 49.2% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2021 | 23 | 23 | $5,175 | $1,266 | 24.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 39 | $7,995 | $3,568 | 44.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 24 | 24 | $6,960 | $3,308 | 47.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 36 | $5,400 | $2,091 | 38.7% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2020 | 19 | 19 | $4,275 | $1,065 | 24.9% |
About Dr. Anthony Gerber, MD
Dr. Anthony Gerber, MD is a Critical Care Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851338008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Gerber, MD has received a total of $8,073 in payments from pharmaceutical and medical device companies, with $7,930 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,910).
As a Medicare-enrolled provider, Gerber has provided services to 388 Medicare beneficiaries, totaling 426 services with total Medicare billing of $39,176. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Lexington, KY
- Active Since 05/31/2006
- Last Updated 10/27/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1851338008
Products in Payments
- NUCALA (Biological) $118.08
- DUPIXENT (Biological) $13.36
- Volara System (Device) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Lexington
Jimmy Smith, D.o, D.O
Critical Care Medicine — Payments: $353,296
John Thompson, M.d, M.D
Critical Care Medicine — Payments: $97,594
Girish Nair, Md, MD
Critical Care Medicine — Payments: $75,636
Adam Betz, M.d, M.D
Critical Care Medicine — Payments: $22,193
Dr. Theresa Case, D.o, D.O
Critical Care Medicine — Payments: $15,431
Eliseo Colon-Carreras, Md, MD
Critical Care Medicine — Payments: $8,414